Dr. Lebastchi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1516 San Pablo St
Fl 5
Los Angeles, CA 90033Phone+1 323-865-3700
Education & Training
- University of MichiganResidency, Urology, 2014 - 2018
- University of Hamburg FOMClass of 2009
Certifications & Licensure![](https://directory.doximity.com/assets/icons/icon-help-e9f0b148a1e6d1f037dde9f26f025c36bd7c99fd4fe31fd76792996fa2aa5e66.svg)
- CA State Medical License 2020 - 2026
- DC State Medical License 2018 - 2024
- CT State Medical License 2017 - 2023
- MD State Medical License 2019 - 2020
- MI State Medical License 2014 - 2019
- American Board of Urology Urology
Publications & Presentations
PubMed
- Identifying the best candidate for focal therapy: a comprehensive review.Alireza Ghoreifi, Leonard Gomella, Jim C Hu, Badrinath Konety, Luca Lunelli
Prostate Cancer and Prostatic Diseases. 2024-10-23 - 1 citationsTiming, incidence and management of delayed bleeding after partial nephrectomy in patients at risk for recurrent, bilateral, multifocal renal tumors.Patrick T Gomella, Julie Solomon, Michael Ahdoot, Sandeep Gurram, Amir H Lebastchi
Urologic Oncology. 2024-07-01 - Salvage High-Intensity Focused Ultrasound for Prostate Cancer after Radiation Failure: A Narrative Review.Sina Sobhani, Anosh Dadabhoy, Alireza Ghoreifi, Amir H Lebastchi
Current Oncology. 2024-06-26
Press Mentions
- 'Routine' Use of Focal Therapy for Prostate Cancer in Next 5 YearsJuly 28th, 2021
- Aerobic Exercise Reduces BP in Resistant HypertensionAugust 7th, 2021
- Androgen Blockers Likely Boost Survival in Older Men with Nonmetastatic CR Prostate CancerAugust 10th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: